Kågedal Matts, Varnäs Katarina, Hooker Andrew C, Karlsson Mats O
AstraZeneca R&D, SE-151 85, Södertälje, Sweden.
Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Br J Clin Pharmacol. 2015 Jul;80(1):116-27. doi: 10.1111/bcp.12558. Epub 2015 Jun 1.
The simplified reference tissue model (SRTM) is used for estimation of receptor occupancy assuming that the non-displaceable binding in the reference region is identical to the brain regions of interest. The aim of this work was to extend the SRTM to also account for inter-regional differences in non-displaceable concentrations, and to investigate if this model allowed estimation of receptor occupancy using white matter as reference. It was also investigated if an apparent higher affinity in caudate compared with other brain regions, could be better explained by a difference in the extent of non-displaceable binding.
The analysis was based on a PET study in six healthy volunteers using the 5-HT1B receptor radioligand [(11)C]-AZ10419369. The radioligand was given intravenously as a tracer dose alone and following different oral doses of the 5-HT1B receptor antagonist AZD3783. Non-linear mixed effects models were developed where differences between regions in non-specific concentrations were accounted for. The properties of the models were also evaluated by means of simulation studies.
The estimate (95% CI) of Ki(PL) was 10.2 ng ml(-1) (5.4, 15) and 10.4 ng ml(-1) (8.1, 13.6) based on the extended SRTM with white matter as reference and based on the SRTM using cerebellum as reference, respectively. The estimate (95% CI) of Ki(PL) for caudate relative to other brain regions was 55% (48, 62%).
The extended SRTM allows consideration of white matter as reference region when no suitable grey matter region exists. AZD3783 affinity appears to be higher in the caudate compared with other brain regions.
简化参考组织模型(SRTM)用于估计受体占有率,假设参考区域中的非置换性结合与感兴趣的脑区相同。本研究的目的是扩展SRTM,以考虑非置换性浓度的区域间差异,并研究该模型是否允许使用白质作为参考来估计受体占有率。还研究了与其他脑区相比,尾状核中明显更高的亲和力是否可以通过非置换性结合程度的差异得到更好的解释。
该分析基于一项对6名健康志愿者的PET研究,使用5-HT1B受体放射性配体[(11)C]-AZ10419369。单独静脉注射示踪剂量的放射性配体,并在口服不同剂量的5-HT1B受体拮抗剂AZD3783后进行。建立了非线性混合效应模型,其中考虑了区域间非特异性浓度的差异。还通过模拟研究评估了模型的性质。
基于以白质为参考的扩展SRTM和以小脑为参考的SRTM,Ki(PL)的估计值(95%CI)分别为10.2 ng ml(-1)(5.4,15)和10.4 ng ml(-1)(8.1,13.6)。尾状核相对于其他脑区的Ki(PL)估计值(95%CI)为55%(48,62%)。
当不存在合适的灰质区域时,扩展的SRTM允许将白质作为参考区域。与其他脑区相比,AZD3783在尾状核中的亲和力似乎更高。